Weitz & Luxenberg Attorney Plays Key Part in the Negotiation Monsanto has agreed to pay up to $300 million to soybean producers and additional amounts…
Read MoreFirm News: Page 6
Category: Drugs & Devices
W&L Accepting Cases of Patients Harmed by Arthrex iBalance Knee Implant
Weitz & Luxenberg is accepting cases of patients who have required revision surgery or been advised that they need revision surgery due to tibial…
Category: Our Firm
W&L Attorney Ellen Relkin to Speak at New York and New Jersey Conferences
Weitz & Luxenberg attorney Ellen Relkin will speak about the latest developments and best practices for Mass Tort litigation at both the American Bar…
Category: Drugs & Devices
W&L Helping Patients Harmed by Smith & Nephew Knee Replacement Failure
Weitz & Luxenberg is accepting cases of people implanted with the first-generation Smith & Nephew Journey Bi-cruciate Stabilized (BCS) Knee replacement system (Journey I…
Category: Mesothelioma
W&L Wins $25 Million Verdict for California Couple Suffering Asbestos-Related Injuries
Weitz & Luxenberg attorneys Benno Ashrafi and Leonard Sandoval recently secured a $25 million dollar trial verdict for Houshang Sabetian, a former Iranian oil…
Category: Drugs & Devices
W&L Helping Patients Experiencing Blood Clots from Xeljanz Arthritis, Colitis Drug
Weitz & Luxenberg is accepting cases from arthritis and ulcerative colitis patients who have been taking Xeljanz (tofacitinib) or Xeljanz XR and have experienced deep…